<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY accession="ERP150066" alias="7f8e8599-1fff-4142-90ee-3dd2d17ef2be" center_name="European Centre for Disease Prevention and Control">
    <IDENTIFIERS>
      <PRIMARY_ID>ERP150066</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject">PRJEB64895</EXTERNAL_ID>
      <SUBMITTER_ID namespace="European Centre for Disease Prevention and Control">7f8e8599-1fff-4142-90ee-3dd2d17ef2be</SUBMITTER_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Emergence and persistent spread of carbapenemase-producing Klebsiella pneumoniae high-risk clones in Greek hospitals, 2013 – 2022</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Other"/>
      <STUDY_ABSTRACT>Analysis of the whole genome sequencing and epidemiological data of 483 carbapenem-resistant Klebsiella pneumoniae isolates from Greek hospitals that participated in the European Survey of Carbapenemase-producing Enterobacterales (2013), in the survey of carbapenem- and/or colistin-resistant Enterobacterales (2019) and in a national follow-up survey (2022) revealed persistent spread of carbapenemase-producing K. pneumoniae high-risk clones including sequence type ST11, ST147, and ST258/512 over a ten-year period, and the recent emergence and establishment of ST323 and ST39 associated to ongoing within-hospital transmission.</STUDY_ABSTRACT>
      <STUDY_DESCRIPTION>Analysis of the whole genome sequencing and epidemiological data of 483 carbapenem-resistant Klebsiella pneumoniae isolates from Greek hospitals that participated in the European Survey of Carbapenemase-producing Enterobacterales (2013), in the survey of carbapenem- and/or colistin-resistant Enterobacterales (2019) and in a national follow-up survey (2022) revealed persistent spread of carbapenemase-producing K. pneumoniae high-risk clones including sequence type ST11, ST147, and ST258/512 over a ten-year period, and the recent emergence and establishment of ST323 and ST39 associated to ongoing within-hospital transmission.</STUDY_DESCRIPTION>
    </DESCRIPTOR>
    <STUDY_ATTRIBUTES>
      <STUDY_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2023-09-01</VALUE>
      </STUDY_ATTRIBUTE>
      <STUDY_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2023-09-01</VALUE>
      </STUDY_ATTRIBUTE>
    </STUDY_ATTRIBUTES>
  </STUDY>
</STUDY_SET>
